{"id":343525,"date":"2025-08-24T05:33:15","date_gmt":"2025-08-24T05:33:15","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-organon\/"},"modified":"2025-08-24T05:33:15","modified_gmt":"2025-08-24T05:33:15","slug":"how-to-buy-organon","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/","title":{"rendered":"Organon &#038; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Organon &#038; Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-343525","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Organon & Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon & Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Organon & Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon & Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Organon & Co. (OGN) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenin; mevcut fiyat, riskler ve 2025-2030 tahminleri dahil tam yat\u0131r\u0131m analizimizle ak\u0131ll\u0131 ticaret kararlar\u0131 verin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Organon & Co. (OGN) hisseleri nas\u0131l al\u0131n\u0131r \u00f6\u011frenin; mevcut fiyat, riskler ve 2025-2030 tahminleri dahil tam yat\u0131r\u0131m analizimizle ak\u0131ll\u0131 ticaret kararlar\u0131 verin."},"intro":"Kad\u0131n sa\u011fl\u0131\u011f\u0131na odaklanan bir ila\u00e7 \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Organon & Co. (OGN), sa\u011fl\u0131k sekt\u00f6r\u00fcnde benzersiz bir f\u0131rsat sunuyor. Bu \u015firket, Merck'ten ayr\u0131larak \u00f6zellikle kad\u0131n sa\u011fl\u0131\u011f\u0131 ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lamak \u00fczere kuruldu ve b\u00fcy\u00fcyen bir pazarda uzmanla\u015fm\u0131\u015f bir oyuncu haline geldi. OGN hisselerine yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi\u2014mevcut performanstan gelecekteki potansiyele kadar\u2014ayr\u0131nt\u0131l\u0131 olarak inceleyece\u011fiz.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kad\u0131n sa\u011fl\u0131\u011f\u0131na odaklanan bir ila\u00e7 \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Organon & Co. (OGN), sa\u011fl\u0131k sekt\u00f6r\u00fcnde benzersiz bir f\u0131rsat sunuyor. Bu \u015firket, Merck'ten ayr\u0131larak \u00f6zellikle kad\u0131n sa\u011fl\u0131\u011f\u0131 ihtiya\u00e7lar\u0131n\u0131 kar\u015f\u0131lamak \u00fczere kuruldu ve b\u00fcy\u00fcyen bir pazarda uzmanla\u015fm\u0131\u015f bir oyuncu haline geldi. OGN hisselerine yat\u0131r\u0131m yaparken bilmeniz gereken her \u015feyi\u2014mevcut performanstan gelecekteki potansiyele kadar\u2014ayr\u0131nt\u0131l\u0131 olarak inceleyece\u011fiz."},"body_html":"<h2>\ud83d\udcc8 Mevcut Hisse Fiyat\u0131 ve \u00d6nemli Tarihler<\/h2> <p>24 A\u011fustos 2025 itibar\u0131yla Organon &amp; Co. (OGN) hisseleri <strong>9,43 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Bu, Mart 2022'deki t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi olan 39,48 $'dan \u00f6nemli bir indirim anlam\u0131na geliyor, ancak May\u0131s 2025'teki 8,01 $'l\u0131k dip seviyesinden de bir toparlanma g\u00f6steriyor.<\/p> <p><strong>Takviminize Not Edin: 30 Ekim 2025<\/strong> OGN yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in bir sonraki kritik tarih bu. \u015eirket, piyasa a\u00e7\u0131lmadan \u00f6nce 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve ard\u0131ndan saat 8:30 ET'de bir konferans g\u00f6r\u00fc\u015fmesi d\u00fczenleyecek. Kazan\u00e7 raporlar\u0131 tarihsel olarak bu hisse senedinde \u00f6nemli hareketlere neden olmu\u015ftur.<\/p> <p><strong>Kazan\u00e7 Raporlar\u0131n\u0131n OGN Hisselerine Etkisi:<\/strong><\/p> <ul> <li><strong>5 A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131, 1,00 $ EPS ile 0,94 $ tahminine kar\u015f\u0131l\u0131k - hisse pozitif ivme g\u00f6sterdi<\/li> <li><strong>\u00d6nceki \u00e7eyrek<\/strong>: 1,02 $ EPS, 0,89 $ konsens\u00fcs tahminini %14,61 a\u015farak \u00f6nemli pozitif s\u00fcrpriz yaratt\u0131<\/li> <li><strong>Tarihsel desen<\/strong>: OGN, kazan\u00e7 tahminlerini s\u00fcrekli a\u015farak bilgili yat\u0131r\u0131mc\u0131lar i\u00e7in f\u0131rsatlar yaratt\u0131<\/li> <\/ul> <p>Yakla\u015fan 3. \u00e7eyrek raporu, y\u0131ll\u0131k bazda %16,96 azalma ile 0,93 $ EPS bekliyor. Bu, \u00f6nemli fiyat hareketlerine yol a\u00e7abilecek klasik bir \"a\u015fma ya da ka\u00e7\u0131rma\" senaryosu yarat\u0131yor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h2> <p>Organon hisseleri son alt\u0131 ayda a\u015f\u0131r\u0131 volatilite ya\u015fad\u0131, baz\u0131 dramatik dalgalanmalar oldu:<\/p> <ul> <li><strong>\u015eubat-Mart 2025<\/strong>: \u015eirket stratejik zorluklar\u0131 a\u015farken 12-14 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<\/li> <li><strong>Nisan-May\u0131s 2025<\/strong>: Temett\u00fc kesintileri ve hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratan kazan\u00e7lar sonras\u0131 %30 keskin d\u00fc\u015f\u00fc\u015f<\/li> <li><strong>14 May\u0131s 2025<\/strong>: Analist not d\u00fc\u015f\u00fcrmeleri ve likidite endi\u015feleri aras\u0131nda t\u00fcm zamanlar\u0131n en d\u00fc\u015f\u00fck seviyesi olan 8,01 $'a ula\u015ft\u0131<\/li> <li><strong>Haziran-Temmuz 2025<\/strong>: Bor\u00e7 azaltma \u00e7abalar\u0131n\u0131n ilerlemesiyle 9-10 $ aral\u0131\u011f\u0131nda kademeli toparlanma<\/li> <li><strong>A\u011fustos 2025<\/strong>: \u0130yile\u015fen 2. \u00e7eyrek sonu\u00e7lar\u0131 ve y\u00fckseltilen rehberlikle 9,43 $ civar\u0131nda istikrar sa\u011fland\u0131<\/li> <\/ul> <p><strong>Volatilitenin nedeni nedir?<\/strong><\/p> <ul> <li>Geliri a\u015f\u0131nd\u0131ran jenerik rekabet (Biyobenzerler %17, Markalar %11 azald\u0131)<\/li> <li>\u00d6nemli \u00fcr\u00fcnlerde m\u00fcnhas\u0131rl\u0131k kayb\u0131<\/li> <li>Agresif geri \u00f6demeler gerektiren y\u00fcksek bor\u00e7 y\u00fck\u00fc<\/li> <li>Fiyat hedefleri 10 $ ile 24 $ aras\u0131nda de\u011fi\u015fen kar\u0131\u015f\u0131k analist g\u00f6r\u00fc\u015fleri<\/li> <\/ul> <p>Zorluklara ra\u011fmen, Kad\u0131n Sa\u011fl\u0131\u011f\u0131 segmenti Nexplanon'un y\u0131ll\u0131k %7,2 b\u00fcy\u00fcmesiyle dayan\u0131kl\u0131l\u0131k g\u00f6sterdi ve dalgalanma aras\u0131nda bir istikrar sa\u011flad\u0131.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, beklenenler \u015funlard\u0131r:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: Ortalama 18,07 $ (10,45 $-25,69 $ aral\u0131\u011f\u0131nda) - <strong>%92 potansiyel art\u0131\u015f<\/strong> <ul> <li>Eyl\u00fcl 2025: 13,84 $ hedef (+%47 mevcut fiyattan)<\/li> <li>Aral\u0131k 2025: 19,59 $ hedef (+%109 mevcut fiyattan)<\/li> <\/ul> <\/li> <li><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: Daha temkinli, hedefler 7,79 $-9,58 $ aras\u0131nda <ul> <li>2025 kazan\u00e7lar\u0131ndan sonra konsolidasyon bekleniyor<\/li> <li>Ocak 2026: 8,59 $ hedef<\/li> <li>Haziran 2026 dip: 7,79 $ projeksiyonu<\/li> <li>Aral\u0131k 2026: 9,58 $ hedef<\/li> <\/ul> <\/li> <li><strong>2028-2030 Projeksiyonlar\u0131<\/strong>: \u015eu anda s\u0131n\u0131rl\u0131 analist kapsam\u0131 mevcut <ul> <li>Uzun vadeli ba\u015far\u0131 kad\u0131n sa\u011fl\u0131\u011f\u0131 inovasyon hatt\u0131na ba\u011fl\u0131<\/li> <li>Geli\u015fmekte olan ekonomilerde pazar geni\u015flemesi b\u00fcy\u00fcmeyi tetikleyebilir<\/li> <li>Rekabet stabil hale gelirse biyobenzerler segmentinde potansiyel<\/li> <\/ul> <\/li> <\/ul> <p><strong>Mevcut Analist Konsens\u00fcs\u00fc<\/strong>:<\/p> <ul> <li>Ortalama fiyat hedefi: 18,00 $ (%90 yukar\u0131 potansiyel)<\/li> <li>Y\u00fcksek hedef: 24,00 $ (+%154)<\/li> <li>D\u00fc\u015f\u00fck hedef: 10,00 $ (+%6)<\/li> <li>Derecelendirme: 2,63\/5 ortalama puan ile \"Orta Al\"<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Volatiliteyi tolere edebilen uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in <strong>AL<\/strong>. Mevcut fiyat, y\u00f6netim ba\u015far\u0131l\u0131 bir d\u00f6n\u00fc\u015f\u00fcm stratejisi uygularsa \u00f6nemli bir yukar\u0131 potansiyel sunuyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>A\u015f\u0131r\u0131 Volatilite<\/strong>: Ge\u00e7en y\u0131l %52 d\u00fc\u015f\u00fc\u015f ve %20'nin \u00fczerinde \u00e7oklu tek g\u00fcnl\u00fck hareketler<\/li> <li><strong>Hukuki Zorluklar<\/strong>: A\u011fustos 2025'te temett\u00fc iddialar\u0131yla ilgili menkul k\u0131ymet doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 davas\u0131 a\u00e7\u0131ld\u0131<\/li> <li><strong>Jenerik Rekabet<\/strong>: Biyobenzer gelirleri %17, markalar %11 azald\u0131, m\u00fcnhas\u0131rl\u0131k kayb\u0131 nedeniyle<\/li> <li><strong>Bor\u00e7 Y\u00fck\u00fc<\/strong>: 2. \u00e7eyrekte 345 milyon $ geri \u00f6deme yap\u0131lmas\u0131na ra\u011fmen, kald\u0131ra\u00e7 b\u00fcy\u00fcme yat\u0131r\u0131mlar\u0131n\u0131 s\u0131n\u0131rl\u0131yor<\/li> <li><strong>Reg\u00fclasyon Bask\u0131s\u0131<\/strong>: ABD'de %200'e varan ila\u00e7 tarifeleri ve devam eden ila\u00e7 sekt\u00f6r\u00fc denetimi riski<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Kazan\u00e7 A\u015fma Deseni<\/strong>: Analist beklentilerini s\u00fcrekli a\u015fma (2. \u00e7eyrek: 1,00 $ vs 0,94 $)<\/li> <li><strong>Bor\u00e7 Azaltma \u0130lerlemesi<\/strong>: 2. \u00e7eyrekte 345 milyon $ geri \u00f6dendi, y\u0131l sonuna kadar net bor\u00e7\/EBITDA'n\u0131n 4,0x alt\u0131nda olmas\u0131 hedefleniyor<\/li> <li><strong>Y\u00fckseltilen Rehberlik<\/strong>: Y\u0131ll\u0131k gelir beklentisi 6,275 milyar $-6,375 milyar $ aral\u0131\u011f\u0131na y\u00fckseltildi<\/li> <li><strong>Kad\u0131n Sa\u011fl\u0131\u011f\u0131 G\u00fcc\u00fc<\/strong>: Ana segmentte Nexplanon b\u00fcy\u00fcmesi y\u0131ll\u0131k %7,2<\/li> <li><strong>De\u011ferlenmemi\u015f Temeller<\/strong>: 84 de\u011fer puan\u0131, \u00f6nemli bir g\u00fcven marj\u0131 oldu\u011funu g\u00f6steriyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Volatilite g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, dalgalanmalara dayanabilece\u011finiz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine par\u00e7a par\u00e7a al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Potansiyel giri\u015f f\u0131rsatlar\u0131 i\u00e7in 30 Ekim kazan\u00e7lar\u0131n\u0131 takip edin<\/li> <li><strong>Risk Y\u00f6netimi<\/strong>: Ani d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 stop-loss emirleri kullan\u0131n<\/li> <li><strong>Uzun Vadeli Bak\u0131\u015f A\u00e7\u0131s\u0131<\/strong>: Bu, birka\u00e7 \u00e7eyrek s\u00fcrebilecek bir d\u00f6n\u00fc\u015f\u00fcm hikayesi<\/li> <\/ol> <p><strong>Mizahi Bak\u0131\u015f<\/strong>: \"OGN ticareti, ba\u011fl\u0131l\u0131k sorunlar\u0131 olan biriyle \u00e7\u0131kmak gibidir\u2014\u00e7ok drama var, ama bar\u0131\u015fma anlar\u0131 mideniz varsa muhte\u015fem olabilir!\"<\/p> <h2>\u2705 Organon &amp; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NYSE listeli hisseleri ve rekabet\u00e7i \u00fccretleri sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n ve Fonlay\u0131n<\/td><td>Volatil bir hisse i\u00e7in riske atmaya rahat oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>OGN'yi \u0130yice Ara\u015ft\u0131r\u0131n<\/td><td>Yat\u0131r\u0131m yapmadan \u00f6nce riskleri ve potansiyel \u00f6d\u00fclleri anlay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Limit Emirleri Kullan\u0131n<\/td><td>Volatilite s\u0131ras\u0131nda fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>5<\/td><td>Pozisyonunuzu Takip Edin<\/td><td>Kazan\u00e7 tarihleri ve sekt\u00f6r geli\u015fmeleri hakk\u0131nda bilgi sahibi olun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 yeni ba\u015flayanlar i\u00e7in eri\u015filebilir k\u0131lar:<\/p> <ul> <li><strong>Minimum depozito: 5 $<\/strong> - Stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li> <li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> - Herhangi bir kimlik belgesini y\u00fckleyin ve hemen ticarete ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> - Kripto, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k se\u00e7enekleri ile esneklik<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> - Hisse senedi piyasas\u0131 temellerini \u00f6\u011frenmek i\u00e7in sezgisel aray\u00fcz<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, yeni yat\u0131r\u0131mc\u0131lar\u0131n ba\u015flang\u0131\u00e7ta b\u00fcy\u00fck sermaye taahh\u00fct etmeden OGN gibi ger\u00e7ek hisselerle pratik deneyim kazanmalar\u0131n\u0131 sa\u011flar.<\/p> <h2>\ud83c\udf0d 2025'te Organon: Kad\u0131n Sa\u011fl\u0131\u011f\u0131 Uzman\u0131<\/h2> <p>Organon &amp; Co., tamamen kad\u0131n sa\u011fl\u0131\u011f\u0131 ihtiya\u00e7lar\u0131na odaklanan ba\u011f\u0131ms\u0131z bir ila\u00e7 \u015firketi olarak faaliyet g\u00f6stermektedir. \u015eirket, 2021'de Merck'ten ayr\u0131larak kad\u0131n sa\u011fl\u0131\u011f\u0131 lideri olma amac\u0131yla kuruldu.<\/p> <p><strong>\u0130\u015f Segmentleri:<\/strong><\/p> <ul> <li><strong>Kad\u0131n Sa\u011fl\u0131\u011f\u0131 (%27 gelir):<\/strong> Kontrasepsiyon, do\u011furganl\u0131k, anne sa\u011fl\u0131\u011f\u0131 \u00fcr\u00fcnleri, amiral gemisi Nexplanon implant dahil<\/li> <li><strong>Biyobenzerler (%8 gelir):<\/strong> Hadlima dahil daha uygun fiyatl\u0131 tedavi se\u00e7enekleri<\/li> <li><strong>Olu\u015fmu\u015f Markalar (%64 gelir):<\/strong> \u00c7e\u015fitli terap\u00f6tik alanlarda olgun \u00fcr\u00fcnler<\/li> <\/ul> <p><strong>Son Stratejik Hamleler:<\/strong><\/p> <ul> <li>A\u011fustos 2025: Myanmar pazar eri\u015fimini geni\u015fletmek i\u00e7in Zuellig Pharma ile ortakl\u0131k<\/li> <li>Nisan 2025: Biogen'den Tofidence haklar\u0131n\u0131n sat\u0131n al\u0131nmas\u0131<\/li> <li>Aral\u0131k 2024: Avrupa migren tedavisi da\u011f\u0131t\u0131m\u0131 i\u00e7in Eli Lilly ile anla\u015fma<\/li> <li>2025 2. \u00e7eyrekte 345 milyon $ bor\u00e7 geri \u00f6demesi, finansal istikrar\u0131 art\u0131rd\u0131<\/li> <\/ul> <p>\u015eirket, d\u00fcnya genelinde yakla\u015f\u0131k 10.000 \u00e7al\u0131\u015fan\u0131yla 140'tan fazla pazara hizmet veriyor ve \"kad\u0131nlar, aileleri ve ilgilendikleri topluluklar i\u00e7in fark yaratan bir d\u00fcnya\" yaratmay\u0131 hedefliyor.<\/p> <p><strong>\u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: 2025'te Organon'un ara\u015ft\u0131rma ekibi, klinik deneylerde umut verici sonu\u00e7lar g\u00f6steren devrim niteli\u011finde hormon i\u00e7ermeyen, talep \u00fczerine kontraseptif bir se\u00e7enek geli\u015ftirdi\u2014bu, d\u00fcnya \u00e7ap\u0131nda kad\u0131n sa\u011fl\u0131\u011f\u0131na eri\u015fimi d\u00f6n\u00fc\u015ft\u00fcrebilir!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Mevcut Hisse Fiyat\u0131 ve \u00d6nemli Tarihler<\/h2>\n<p>24 A\u011fustos 2025 itibar\u0131yla Organon &amp; Co. (OGN) hisseleri <strong>9,43 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Bu, Mart 2022&#8217;deki t\u00fcm zamanlar\u0131n en y\u00fcksek seviyesi olan 39,48 $&#8217;dan \u00f6nemli bir indirim anlam\u0131na geliyor, ancak May\u0131s 2025&#8217;teki 8,01 $&#8217;l\u0131k dip seviyesinden de bir toparlanma g\u00f6steriyor.<\/p>\n<p><strong>Takviminize Not Edin: 30 Ekim 2025<\/strong> OGN yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in bir sonraki kritik tarih bu. \u015eirket, piyasa a\u00e7\u0131lmadan \u00f6nce 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak ve ard\u0131ndan saat 8:30 ET&#8217;de bir konferans g\u00f6r\u00fc\u015fmesi d\u00fczenleyecek. Kazan\u00e7 raporlar\u0131 tarihsel olarak bu hisse senedinde \u00f6nemli hareketlere neden olmu\u015ftur.<\/p>\n<p><strong>Kazan\u00e7 Raporlar\u0131n\u0131n OGN Hisselerine Etkisi:<\/strong><\/p>\n<ul>\n<li><strong>5 A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri a\u015ft\u0131, 1,00 $ EPS ile 0,94 $ tahminine kar\u015f\u0131l\u0131k &#8211; hisse pozitif ivme g\u00f6sterdi<\/li>\n<li><strong>\u00d6nceki \u00e7eyrek<\/strong>: 1,02 $ EPS, 0,89 $ konsens\u00fcs tahminini %14,61 a\u015farak \u00f6nemli pozitif s\u00fcrpriz yaratt\u0131<\/li>\n<li><strong>Tarihsel desen<\/strong>: OGN, kazan\u00e7 tahminlerini s\u00fcrekli a\u015farak bilgili yat\u0131r\u0131mc\u0131lar i\u00e7in f\u0131rsatlar yaratt\u0131<\/li>\n<\/ul>\n<p>Yakla\u015fan 3. \u00e7eyrek raporu, y\u0131ll\u0131k bazda %16,96 azalma ile 0,93 $ EPS bekliyor. Bu, \u00f6nemli fiyat hareketlerine yol a\u00e7abilecek klasik bir &#8220;a\u015fma ya da ka\u00e7\u0131rma&#8221; senaryosu yarat\u0131yor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Seyri ve Trend Analizi<\/h2>\n<p>Organon hisseleri son alt\u0131 ayda a\u015f\u0131r\u0131 volatilite ya\u015fad\u0131, baz\u0131 dramatik dalgalanmalar oldu:<\/p>\n<ul>\n<li><strong>\u015eubat-Mart 2025<\/strong>: \u015eirket stratejik zorluklar\u0131 a\u015farken 12-14 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rd\u00fc<\/li>\n<li><strong>Nisan-May\u0131s 2025<\/strong>: Temett\u00fc kesintileri ve hayal k\u0131r\u0131kl\u0131\u011f\u0131 yaratan kazan\u00e7lar sonras\u0131 %30 keskin d\u00fc\u015f\u00fc\u015f<\/li>\n<li><strong>14 May\u0131s 2025<\/strong>: Analist not d\u00fc\u015f\u00fcrmeleri ve likidite endi\u015feleri aras\u0131nda t\u00fcm zamanlar\u0131n en d\u00fc\u015f\u00fck seviyesi olan 8,01 $&#8217;a ula\u015ft\u0131<\/li>\n<li><strong>Haziran-Temmuz 2025<\/strong>: Bor\u00e7 azaltma \u00e7abalar\u0131n\u0131n ilerlemesiyle 9-10 $ aral\u0131\u011f\u0131nda kademeli toparlanma<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: \u0130yile\u015fen 2. \u00e7eyrek sonu\u00e7lar\u0131 ve y\u00fckseltilen rehberlikle 9,43 $ civar\u0131nda istikrar sa\u011fland\u0131<\/li>\n<\/ul>\n<p><strong>Volatilitenin nedeni nedir?<\/strong><\/p>\n<ul>\n<li>Geliri a\u015f\u0131nd\u0131ran jenerik rekabet (Biyobenzerler %17, Markalar %11 azald\u0131)<\/li>\n<li>\u00d6nemli \u00fcr\u00fcnlerde m\u00fcnhas\u0131rl\u0131k kayb\u0131<\/li>\n<li>Agresif geri \u00f6demeler gerektiren y\u00fcksek bor\u00e7 y\u00fck\u00fc<\/li>\n<li>Fiyat hedefleri 10 $ ile 24 $ aras\u0131nda de\u011fi\u015fen kar\u0131\u015f\u0131k analist g\u00f6r\u00fc\u015fleri<\/li>\n<\/ul>\n<p>Zorluklara ra\u011fmen, Kad\u0131n Sa\u011fl\u0131\u011f\u0131 segmenti Nexplanon&#8217;un y\u0131ll\u0131k %7,2 b\u00fcy\u00fcmesiyle dayan\u0131kl\u0131l\u0131k g\u00f6sterdi ve dalgalanma aras\u0131nda bir istikrar sa\u011flad\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firket temellerine dayanarak, beklenenler \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: Ortalama 18,07 $ (10,45 $-25,69 $ aral\u0131\u011f\u0131nda) &#8211; <strong>%92 potansiyel art\u0131\u015f<\/strong>\n<ul>\n<li>Eyl\u00fcl 2025: 13,84 $ hedef (+%47 mevcut fiyattan)<\/li>\n<li>Aral\u0131k 2025: 19,59 $ hedef (+%109 mevcut fiyattan)<\/li>\n<\/ul>\n<\/li>\n<li><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: Daha temkinli, hedefler 7,79 $-9,58 $ aras\u0131nda\n<ul>\n<li>2025 kazan\u00e7lar\u0131ndan sonra konsolidasyon bekleniyor<\/li>\n<li>Ocak 2026: 8,59 $ hedef<\/li>\n<li>Haziran 2026 dip: 7,79 $ projeksiyonu<\/li>\n<li>Aral\u0131k 2026: 9,58 $ hedef<\/li>\n<\/ul>\n<\/li>\n<li><strong>2028-2030 Projeksiyonlar\u0131<\/strong>: \u015eu anda s\u0131n\u0131rl\u0131 analist kapsam\u0131 mevcut\n<ul>\n<li>Uzun vadeli ba\u015far\u0131 kad\u0131n sa\u011fl\u0131\u011f\u0131 inovasyon hatt\u0131na ba\u011fl\u0131<\/li>\n<li>Geli\u015fmekte olan ekonomilerde pazar geni\u015flemesi b\u00fcy\u00fcmeyi tetikleyebilir<\/li>\n<li>Rekabet stabil hale gelirse biyobenzerler segmentinde potansiyel<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><strong>Mevcut Analist Konsens\u00fcs\u00fc<\/strong>:<\/p>\n<ul>\n<li>Ortalama fiyat hedefi: 18,00 $ (%90 yukar\u0131 potansiyel)<\/li>\n<li>Y\u00fcksek hedef: 24,00 $ (+%154)<\/li>\n<li>D\u00fc\u015f\u00fck hedef: 10,00 $ (+%6)<\/li>\n<li>Derecelendirme: 2,63\/5 ortalama puan ile &#8220;Orta Al&#8221;<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Volatiliteyi tolere edebilen uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in <strong>AL<\/strong>. Mevcut fiyat, y\u00f6netim ba\u015far\u0131l\u0131 bir d\u00f6n\u00fc\u015f\u00fcm stratejisi uygularsa \u00f6nemli bir yukar\u0131 potansiyel sunuyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>A\u015f\u0131r\u0131 Volatilite<\/strong>: Ge\u00e7en y\u0131l %52 d\u00fc\u015f\u00fc\u015f ve %20&#8217;nin \u00fczerinde \u00e7oklu tek g\u00fcnl\u00fck hareketler<\/li>\n<li><strong>Hukuki Zorluklar<\/strong>: A\u011fustos 2025&#8217;te temett\u00fc iddialar\u0131yla ilgili menkul k\u0131ymet doland\u0131r\u0131c\u0131l\u0131\u011f\u0131 davas\u0131 a\u00e7\u0131ld\u0131<\/li>\n<li><strong>Jenerik Rekabet<\/strong>: Biyobenzer gelirleri %17, markalar %11 azald\u0131, m\u00fcnhas\u0131rl\u0131k kayb\u0131 nedeniyle<\/li>\n<li><strong>Bor\u00e7 Y\u00fck\u00fc<\/strong>: 2. \u00e7eyrekte 345 milyon $ geri \u00f6deme yap\u0131lmas\u0131na ra\u011fmen, kald\u0131ra\u00e7 b\u00fcy\u00fcme yat\u0131r\u0131mlar\u0131n\u0131 s\u0131n\u0131rl\u0131yor<\/li>\n<li><strong>Reg\u00fclasyon Bask\u0131s\u0131<\/strong>: ABD&#8217;de %200&#8217;e varan ila\u00e7 tarifeleri ve devam eden ila\u00e7 sekt\u00f6r\u00fc denetimi riski<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Kazan\u00e7 A\u015fma Deseni<\/strong>: Analist beklentilerini s\u00fcrekli a\u015fma (2. \u00e7eyrek: 1,00 $ vs 0,94 $)<\/li>\n<li><strong>Bor\u00e7 Azaltma \u0130lerlemesi<\/strong>: 2. \u00e7eyrekte 345 milyon $ geri \u00f6dendi, y\u0131l sonuna kadar net bor\u00e7\/EBITDA&#8217;n\u0131n 4,0x alt\u0131nda olmas\u0131 hedefleniyor<\/li>\n<li><strong>Y\u00fckseltilen Rehberlik<\/strong>: Y\u0131ll\u0131k gelir beklentisi 6,275 milyar $-6,375 milyar $ aral\u0131\u011f\u0131na y\u00fckseltildi<\/li>\n<li><strong>Kad\u0131n Sa\u011fl\u0131\u011f\u0131 G\u00fcc\u00fc<\/strong>: Ana segmentte Nexplanon b\u00fcy\u00fcmesi y\u0131ll\u0131k %7,2<\/li>\n<li><strong>De\u011ferlenmemi\u015f Temeller<\/strong>: 84 de\u011fer puan\u0131, \u00f6nemli bir g\u00fcven marj\u0131 oldu\u011funu g\u00f6steriyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Volatilite g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, dalgalanmalara dayanabilece\u011finiz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Tek seferlik b\u00fcy\u00fck al\u0131m yerine par\u00e7a par\u00e7a al\u0131m yapmay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Potansiyel giri\u015f f\u0131rsatlar\u0131 i\u00e7in 30 Ekim kazan\u00e7lar\u0131n\u0131 takip edin<\/li>\n<li><strong>Risk Y\u00f6netimi<\/strong>: Ani d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 stop-loss emirleri kullan\u0131n<\/li>\n<li><strong>Uzun Vadeli Bak\u0131\u015f A\u00e7\u0131s\u0131<\/strong>: Bu, birka\u00e7 \u00e7eyrek s\u00fcrebilecek bir d\u00f6n\u00fc\u015f\u00fcm hikayesi<\/li>\n<\/ol>\n<p><strong>Mizahi Bak\u0131\u015f<\/strong>: &#8220;OGN ticareti, ba\u011fl\u0131l\u0131k sorunlar\u0131 olan biriyle \u00e7\u0131kmak gibidir\u2014\u00e7ok drama var, ama bar\u0131\u015fma anlar\u0131 mideniz varsa muhte\u015fem olabilir!&#8221;<\/p>\n<h2>\u2705 Organon &amp; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NYSE listeli hisseleri ve rekabet\u00e7i \u00fccretleri sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n ve Fonlay\u0131n<\/td>\n<td>Volatil bir hisse i\u00e7in riske atmaya rahat oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>OGN&#8217;yi \u0130yice Ara\u015ft\u0131r\u0131n<\/td>\n<td>Yat\u0131r\u0131m yapmadan \u00f6nce riskleri ve potansiyel \u00f6d\u00fclleri anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit Emirleri Kullan\u0131n<\/td>\n<td>Volatilite s\u0131ras\u0131nda fazla \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Pozisyonunuzu Takip Edin<\/td>\n<td>Kazan\u00e7 tarihleri ve sekt\u00f6r geli\u015fmeleri hakk\u0131nda bilgi sahibi olun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Pocket Option, hisse senedi yat\u0131r\u0131m\u0131n\u0131 yeni ba\u015flayanlar i\u00e7in eri\u015filebilir k\u0131lar:<\/p>\n<ul>\n<li><strong>Minimum depozito: 5 $<\/strong> &#8211; Stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li>\n<li><strong>1 dakikal\u0131k KYC do\u011frulamas\u0131<\/strong> &#8211; Herhangi bir kimlik belgesini y\u00fckleyin ve hemen ticarete ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong> &#8211; Kripto, e-c\u00fczdanlar ve geleneksel bankac\u0131l\u0131k se\u00e7enekleri ile esneklik<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> &#8211; Hisse senedi piyasas\u0131 temellerini \u00f6\u011frenmek i\u00e7in sezgisel aray\u00fcz<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, yeni yat\u0131r\u0131mc\u0131lar\u0131n ba\u015flang\u0131\u00e7ta b\u00fcy\u00fck sermaye taahh\u00fct etmeden OGN gibi ger\u00e7ek hisselerle pratik deneyim kazanmalar\u0131n\u0131 sa\u011flar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Organon: Kad\u0131n Sa\u011fl\u0131\u011f\u0131 Uzman\u0131<\/h2>\n<p>Organon &amp; Co., tamamen kad\u0131n sa\u011fl\u0131\u011f\u0131 ihtiya\u00e7lar\u0131na odaklanan ba\u011f\u0131ms\u0131z bir ila\u00e7 \u015firketi olarak faaliyet g\u00f6stermektedir. \u015eirket, 2021&#8217;de Merck&#8217;ten ayr\u0131larak kad\u0131n sa\u011fl\u0131\u011f\u0131 lideri olma amac\u0131yla kuruldu.<\/p>\n<p><strong>\u0130\u015f Segmentleri:<\/strong><\/p>\n<ul>\n<li><strong>Kad\u0131n Sa\u011fl\u0131\u011f\u0131 (%27 gelir):<\/strong> Kontrasepsiyon, do\u011furganl\u0131k, anne sa\u011fl\u0131\u011f\u0131 \u00fcr\u00fcnleri, amiral gemisi Nexplanon implant dahil<\/li>\n<li><strong>Biyobenzerler (%8 gelir):<\/strong> Hadlima dahil daha uygun fiyatl\u0131 tedavi se\u00e7enekleri<\/li>\n<li><strong>Olu\u015fmu\u015f Markalar (%64 gelir):<\/strong> \u00c7e\u015fitli terap\u00f6tik alanlarda olgun \u00fcr\u00fcnler<\/li>\n<\/ul>\n<p><strong>Son Stratejik Hamleler:<\/strong><\/p>\n<ul>\n<li>A\u011fustos 2025: Myanmar pazar eri\u015fimini geni\u015fletmek i\u00e7in Zuellig Pharma ile ortakl\u0131k<\/li>\n<li>Nisan 2025: Biogen&#8217;den Tofidence haklar\u0131n\u0131n sat\u0131n al\u0131nmas\u0131<\/li>\n<li>Aral\u0131k 2024: Avrupa migren tedavisi da\u011f\u0131t\u0131m\u0131 i\u00e7in Eli Lilly ile anla\u015fma<\/li>\n<li>2025 2. \u00e7eyrekte 345 milyon $ bor\u00e7 geri \u00f6demesi, finansal istikrar\u0131 art\u0131rd\u0131<\/li>\n<\/ul>\n<p>\u015eirket, d\u00fcnya genelinde yakla\u015f\u0131k 10.000 \u00e7al\u0131\u015fan\u0131yla 140&#8217;tan fazla pazara hizmet veriyor ve &#8220;kad\u0131nlar, aileleri ve ilgilendikleri topluluklar i\u00e7in fark yaratan bir d\u00fcnya&#8221; yaratmay\u0131 hedefliyor.<\/p>\n<p><strong>\u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: 2025&#8217;te Organon&#8217;un ara\u015ft\u0131rma ekibi, klinik deneylerde umut verici sonu\u00e7lar g\u00f6steren devrim niteli\u011finde hormon i\u00e7ermeyen, talep \u00fczerine kontraseptif bir se\u00e7enek geli\u015ftirdi\u2014bu, d\u00fcnya \u00e7ap\u0131nda kad\u0131n sa\u011fl\u0131\u011f\u0131na eri\u015fimi d\u00f6n\u00fc\u015ft\u00fcrebilir!<\/p>\n"},"faq":[{"question":"Organon & Co. hisseleri nereden al\u0131nabilir?","answer":"Organon & Co. hisseleri, NYSE'de listelenmi\u015ftir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"OGN hisseleri i\u00e7in riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda a\u015f\u0131r\u0131 volatilite, yasal davalar, jenerik rekabet, y\u00fcksek bor\u00e7 y\u00fck\u00fc ve d\u00fczenleyici bask\u0131lar bulunmaktad\u0131r."},{"question":"Organon & Co.'nun kad\u0131n sa\u011fl\u0131\u011f\u0131 segmenti ne kadar g\u00fc\u00e7l\u00fc?","answer":"Kad\u0131n sa\u011fl\u0131\u011f\u0131 segmenti \u015firket gelirinin %27'sini olu\u015fturur ve Nexplanon gibi \u00fcr\u00fcnlerle y\u0131ll\u0131k %7,2 b\u00fcy\u00fcme g\u00f6stermektedir."},{"question":"OGN hisseleri i\u00e7in 2025 y\u0131l sonu fiyat hedefi nedir?","answer":"Analistlerin ortalama fiyat hedefi 18,07 $ olup, bu mevcut fiyata g\u00f6re yakla\u015f\u0131k %92'lik bir art\u0131\u015f potansiyeli anlam\u0131na gelir."},{"question":"Yeni ba\u015flayanlar OGN hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p dolar maliyet ortalamas\u0131 yapmalar\u0131, fiyat uyar\u0131lar\u0131 kurmalar\u0131 ve risk y\u00f6netimi stratejileri uygulamalar\u0131 \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Organon & Co. hisseleri nereden al\u0131nabilir?","answer":"Organon & Co. hisseleri, NYSE'de listelenmi\u015ftir ve bir\u00e7ok \u00e7evrimi\u00e7i arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"OGN hisseleri i\u00e7in riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda a\u015f\u0131r\u0131 volatilite, yasal davalar, jenerik rekabet, y\u00fcksek bor\u00e7 y\u00fck\u00fc ve d\u00fczenleyici bask\u0131lar bulunmaktad\u0131r."},{"question":"Organon & Co.'nun kad\u0131n sa\u011fl\u0131\u011f\u0131 segmenti ne kadar g\u00fc\u00e7l\u00fc?","answer":"Kad\u0131n sa\u011fl\u0131\u011f\u0131 segmenti \u015firket gelirinin %27'sini olu\u015fturur ve Nexplanon gibi \u00fcr\u00fcnlerle y\u0131ll\u0131k %7,2 b\u00fcy\u00fcme g\u00f6stermektedir."},{"question":"OGN hisseleri i\u00e7in 2025 y\u0131l sonu fiyat hedefi nedir?","answer":"Analistlerin ortalama fiyat hedefi 18,07 $ olup, bu mevcut fiyata g\u00f6re yakla\u015f\u0131k %92'lik bir art\u0131\u015f potansiyeli anlam\u0131na gelir."},{"question":"Yeni ba\u015flayanlar OGN hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p dolar maliyet ortalamas\u0131 yapmalar\u0131, fiyat uyar\u0131lar\u0131 kurmalar\u0131 ve risk y\u00f6netimi stratejileri uygulamalar\u0131 \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Organon &amp; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon &amp; Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Organon &amp; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon &amp; Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T05:33:15+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Organon &#038; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Organon &#038; Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-24T05:33:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/\",\"name\":\"Organon & Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon & Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-24T05:33:15+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Organon &#038; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Organon &#038; Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Organon & Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon & Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/","og_locale":"tr_TR","og_type":"article","og_title":"Organon & Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon & Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T05:33:15+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Organon &#038; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Organon &#038; Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-24T05:33:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/","name":"Organon & Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Organon & Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-24T05:33:15+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-organon\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Organon &#038; Co. (OGN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Organon &#038; Co. (OGN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":343528,"slug":"how-to-buy-organon","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Organon & Co. (OGN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-organon\/"},"pt_AA":{"locale":"pt_AA","id":343523,"slug":"how-to-buy-organon","post_title":"Como comprar a\u00e7\u00f5es da Organon & Co. (OGN) - Investimento em a\u00e7\u00f5es da Organon & Co. (OGN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-organon\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/343525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=343525"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/343525\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=343525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=343525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=343525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}